Allergy Center Charité, Department of Dermatology, Venerology and Allergology, Charité - Universitätsmedizin Berlin, ADAC Air Rescue Service Senftenberg, Department of Dermatology and Venereology, Medical University of Graz, Austria, Department of Pediatrics, Pneumonology and Immunology, Charité - Universitätsmedizin Berlin, Allergy Clinic, Department of Dermatology, SALK, Paracelsus Medical University, Salzburg, Austria, Pediatric Allergology, University Children's Hospital Zurich, Zurich, Switzerland, Department of Dermatology, University Hospital Erlangen-Nürnberg, Department of Pediatric Pneumology and Allergology at the KID Center, Dresden-Friedrichstadt, Department of Dermatology, Venerology and Allergy at the Saarland University, Homburg/Saar, Department of Allergology, Johanniter-Krankenhaus im Fläming Treuenbrietzen GmbH, Treuenbrietzen, Department of Internal Medicine I: Pneumology & Allergology/Immunology, Friedrich Schiller University Jena, Department of Pediatric Pulmonology and Allergology, Children's Hospital of the University of Cologne, Allergy Unit, Department of Dermatology, University Hospital Basel, Basel, Schweiz, Department of Dermatology, Venereology and Allergology, University of Leipzig, Department of Dermatology and Allergology, Ludwig-Maximilian University, Munich, Margitta Worm and Oliver Eckermann have equally contributed to the manuscript.
Dtsch Arztebl Int. 2014 May 23;111(21):367-75. doi: 10.3238/arztebl.2014.0367.
Anaphylaxis is the most severe manifestation of a mast cell-dependent immediate reaction and may be fatal. According to data from the Berlin region, its incidence is 2-3 cases per 100 000 persons per year.
We evaluated data from the anaphylaxis registry of the German-speaking countries for 2006-2013 and data from the protocols of the ADAC air rescue service for 2010-2011 to study the triggers, clinical manifestations, and treatment of anaphylaxis.
The registry contained data on 4141 patients, and the ADAC air rescue protocols concerned 1123 patients. In the registry, the most common triggers for anaphylaxis were insect venom (n = 2074; 50.1%), foods (n = 1039; 25.1%), and drugs (n = 627; 15.1%). Within these groups, the most common triggers were wasp (n = 1460) and bee stings (n = 412), legumes (n = 241), animal proteins (n = 225), and analgesic drugs (n = 277). Food anaphylaxis was most frequently induced by peanuts, cow milk, and hen's egg in children and by wheat and shellfish in adults. An analysis of the medical emergency cases revealed that epinephrine was given for grade 3 or 4 anaphylaxis to 14.5% and 43.9% (respectively) of the patients in the anaphylaxis registry and to 19% and 78% of the patients in the air rescue protocols.
Wasp and bee venom, legumes, animal proteins, and analgesic drugs were the commonest triggers of anaphylaxis. Their relative frequency was age-dependent. Epinephrine was given too rarely, as it is recommended in the guidelines for all cases of grade 2 and above.
过敏反应是肥大细胞依赖的即刻反应的最严重表现形式,可能是致命的。根据柏林地区的数据,其发病率为每年每 100000 人 2-3 例。
我们评估了 2006 年至 2013 年德国过敏反应登记处的数据和 2010 年至 2011 年 ADAC 空中救援服务协议的数据,以研究过敏反应的触发因素、临床表现和治疗方法。
登记处包含了 4141 名患者的数据,ADAC 空中救援协议涉及 1123 名患者。在登记处,过敏反应最常见的诱因是昆虫毒液(n = 2074;50.1%)、食物(n = 1039;25.1%)和药物(n = 627;15.1%)。在这些组中,最常见的诱因是黄蜂(n = 1460)和蜜蜂蜇伤(n = 412)、豆类(n = 241)、动物蛋白(n = 225)和镇痛药(n = 277)。儿童食物过敏最常见的诱因是花生、牛奶和鸡蛋,成人则是小麦和贝类。对医疗急救病例的分析表明,在过敏反应登记处,肾上腺素用于 3 级或 4 级过敏反应的患者比例分别为 14.5%和 43.9%(分别),在空气救援协议中,这一比例分别为 19%和 78%。
黄蜂和蜜蜂毒液、豆类、动物蛋白和镇痛药是过敏反应最常见的诱因。其相对频率与年龄有关。肾上腺素的使用过于频繁,因为指南建议所有 2 级及以上病例都应使用肾上腺素。